Delivery Order SPE2DB22D1002-SPE2DB25FLGU3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,905.74 firm fixed-price delivery order is for the supply of MOVANTIK 12.5 MG TABLET 30S, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price of $1,405.17 and a period of performance through February 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,373.23, is for the delivery of MOVANTIK 25 MG TABLET 30S medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a $3,514.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 25 mg Movantik medication. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 14, 2023 to support DLA's medical supply needs. No subcontractors or set aside...
- This federal contract award is for the delivery of Movantik 25 mg tablets to the Defense Logistics Agency (DLA). The $1,174.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets valued at $4,463.71 under a firm fixed-price contract. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is part...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $49,217.64 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract, issued as a competitive delivery order, represents a continuation of the federal government's reliance on AmerisourceBergen as a critical pharmaceutical distributor for military healthcare systems. The work will be performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGU3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,622.57 to AmerisourceBergen Drug Corp for the supply of MOVANTIK 25 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and was competitively awarded with no set-aside designation. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The firm fixed pricing structure and range of products delivered through this contract vehicle demonstrate AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications and brand-name drugs for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/25/25 |